BNP (Heart Failure Marker) vs COPD Exacerbation Treatment
Medicare Cost Comparison 2025
Quick Answer
BNP (Heart Failure Marker): $50 total · Medicare pays $40 · Patient pays $10
COPD Exacerbation Treatment: $12,000 total · Medicare pays $9,600 · Patient pays $2,400
Cost Comparison
| Metric | BNP (Heart Failure Marker) | COPD Exacerbation Treatment |
|---|---|---|
| Total Average Cost | $50 | $12,000 |
| Medicare Pays | $40 | $9,600 |
| Patient Pays | $10 | $2,400 |
| Category | lab | hospital |
FAQ
What is the cost difference between BNP (Heart Failure Marker) and COPD Exacerbation Treatment?
COPD Exacerbation Treatment costs $12,000 on average, while BNP (Heart Failure Marker) costs $50 — a difference of $11,950.
How much does Medicare pay for BNP (Heart Failure Marker) vs COPD Exacerbation Treatment?
Medicare typically pays $40 for BNP (Heart Failure Marker) (patient owes $10). For COPD Exacerbation Treatment, Medicare pays $9,600 (patient owes $2,400).
What is BNP (Heart Failure Marker)?
Blood test measuring a protein released during heart failure.
What is COPD Exacerbation Treatment?
Hospital treatment for acute worsening of chronic obstructive pulmonary disease.